Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTP273 in Type 2 Diabetes Mellitus
NCT02653599Phase 2Completed
- Sponsor
- vTv Therapeutics
- Start
- Dec 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ttp273 in type 2 diabetes mellitus (T2DM), sponsored by vTv Therapeutics. Started Dec 2015; status: completed.
02
Drugs
ttp273
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02653599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02653599.